IL6 and COVID-19: While immunosuppressants can reduce cytokine storms triggered by TNF, IL-1, IL-6, and interferon, which may mitigate serious organ damage in COVID-19 patients [110], they also increase the risk of infections due to a reduced autoimmune response.